Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Jen-Kou Lin"'
Autor:
Yuan Tzu Lan, Pei Ching Lin, Chun Chi Lin, Chien Hsing Lin, Hung Hsin Lin, Jeng Kai Jiang, Shih Ching Chang, Sheng Chieh Huang, Jen Kou Lin, Shung Haur Yang, Wei Shone Chen, Wen Yi Liang
Publikováno v:
Cancers
Volume 13
Issue 8
Cancers, Vol 13, Iss 1883, p 1883 (2021)
Volume 13
Issue 8
Cancers, Vol 13, Iss 1883, p 1883 (2021)
Background: Few reports have investigated genetic alterations between patients with early and late recurrence following curative surgery for colorectal cancer (CRC). Methods: A total of 1227 stage I–III CRC patients who underwent curative resection
Autor:
Jen Kou Lin, Shung Haur Yang, Hao Wei Teng, Sheng Chieh Huang, Jeng Kai Jiang, Hung Hsin Lin, Shih Ching Chang, Yuan Tzu Lan, Chun Chi Lin, Tzu Chen Lin, Wei Shone Chen, Huann Sheng Wang
Publikováno v:
Journal of Gastrointestinal Surgery. 24:1092-1100
To compare the cost-performance between planned short-course radiation and upfront concurrent chemoradiation on metastatic rectal cancer. A total of 75 patients with metastatic rectal cancer who underwent planned short-course radiation or upfront con
Autor:
Jen-Kou Lin, Francesco Ardito, Jean-Francois Ouellet, Irinel Popescu, Helena Isoniemi, Santiago López-Ben, Catherine Hubert, Luca Viganò, Alessandro Ferrero, Eduardo Barroso, Oleg G Skipenko, Agostino Maria De Rose, Darius F. Mirza, Gernot M. Kaiser, Réal Lapointe, Felice Giuliante, René Adam, Jean-Marc Regimbeau
Publikováno v:
Annals of Surgical Oncology, Vol. 28, no. 13, p. 8198-8208 (2021)
Annals of Surgical Oncology
Annals of Surgical Oncology
Background The liver-first approach in patients with synchronous colorectal liver metastases (CRLM) has gained wide consensus but its role is still to be clarified. We aimed to elucidate the outcome of the liver-first approach and to identify patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3b57ca7c37d8dbb062638542ccce202
https://hdl.handle.net/2078.1/249110
https://hdl.handle.net/2078.1/249110
Autor:
Yuan-Tzu Lan, Shih-Ching Chang, Pei-Ching Lin, Chun-Chi Lin, Hung-Hsin Lin, Shen-Chieh Huang, Chien-Hsing Lin, Wen-Yi Liang, Wei-Shone Chen, Jeng-Kai Jiang, Jen-Kou Lin, Shung-Haur Yang
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe prognosis of mucinous adenocarcinoma (MAC) and non-mucinous adenocarcinoma (NMAC) in colorectal cancer (CRC) is controversial, and the molecular differences between them are unclear.MethodsBetween 2000 and 2010, a total of 1,483 CRC pat
Autor:
Hung Hsin Lin, Chun Chi Lin, Jen Kou Lin, Shung Haur Yang, Wei Shone Chen, Huann Sheng Wang, Chu Cheng Chang, Jeng Kai Jiang, Shih Ching Chang, Tzu Chen Lin, Yuan Tzu Lan
Publikováno v:
World Journal of Surgical Oncology
World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-7 (2019)
World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-7 (2019)
Background Perineal wound complications are a long-lasting issue for abdominoperineal resection (APR) patients. Complication rates as high as 60% have been reported, with the most common complication being delayed perineal wound healing. The aim of t
Autor:
Jen Kou Lin, Jeng Kae Jiang, Shih Ching Chang, Chun Chi Lin, Yuan Tzu Lan, Sheng Chieh Huang, Shung Haur Yang, Wei Shone Chen, Huann Sheng Wang, Tzu Chen Lin, Hung Hsin Lin, Tai Chuan Kuan
Publikováno v:
World journal of surgery. 43(12)
Patients with stage II colorectal cancer (CRC) have a higher risk of recurrence when they have certain risk factors, including clinical and pathological patterns. However, as the prognostic role of molecular patterns for stage II disease is still unc
Autor:
Chu Cheng Chang, Yuan Tzu Lan, Tzu Chen Lin, Jeng Kai Jiang, Shih Ching Chang, Wei Shone Chen, Huann Sheng Wang, Chun Chi Lin, Shung Haur Yang, Jen Kou Lin
Publikováno v:
International Surgery. 103:27-35
Objective: Mutation spectra in colorectal cancer with metastasis and its response to chemotherapy. Summary of Background Data: No molecular markers are available for selecting the optimal chemotherapeutic regimen (irinotecan or oxaliplatin) for metas
Autor:
Chieh Han Chuang, Jen Yi Wang, Joe Bin Chen, Jen Kou Lin, Mei Ching Liu, Chung Rong Changchien, Hong-Hwa Chen
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 14:61-68
Aim This phase II, open-label study evaluated the efficacy and safety of neoadjuvant therapy with bevacizumab plus XELOX (capecitabine and oxaliplatin) for untreated metastatic colorectal cancer with unresectable liver metastases and assessed convers
Autor:
Jen Wei Chou, Wen-Chieh Wu, Jau-Min Wong, Te-Hsin Chao, Ting-An Chang, Jinn-Shiun Chen, Yen-Hsuan Ni, Wei-Chen Lin, Hsu-Heng Yen, Chia-Tung Shun, Cheng-Yi Wang, I-Lun Shih, Tzu-Chi Hsu, Shu-Chen Wei, Horng-Yuan Wang, Ming-Jium Shieh, Chiao-Hsiung Chuang, Deng-Chyang Wu, T. Y. Huang, Yenn-Hwei Chou, Hung-Hsin Lin, Chun Chi Lin, Jen-Kou Lin, Wen-Hung Hsu, Yuk-Ming Tsang, Meng-Tzu Weng
Publikováno v:
Intestinal Research
Intestinal Research, Vol 15, Iss 3, Pp 285-310 (2017)
Intestinal Research, Vol 15, Iss 3, Pp 285-310 (2017)
Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have been steadily increasing. A steering committee was est
Autor:
Jeng Kai Jiang, Shih Ching Chang, Shung Haur Yang, Chun Chi Lin, Sheng Chieh Huang, Jen Kou Lin, Tzu Chen Lin, Wei Shone Chen, Huann Sheng Wang
Publikováno v:
International Surgery. 101:510-516
To figure out the relationship between the tumor marker clearance rate during the treatment period and the disease prognosis. Carcinoembryonic antigen (CEA) is a glycoprotein that has been widely used as a tumor marker in colorectal cancer for more t